Daily Sepsis Research Analysis
Three papers stood out today: a multicenter cohort introduces critical closing pressure and tissue perfusion pressure as complementary hemodynamic metrics to mean arterial pressure for sepsis risk stratification; a systematic review/meta-analysis summarizes AI models for early sepsis detection, highlighting strong performance but limited real-world validation; and an integrative multi-omics study maps dysregulated programmed cell death pathways in sepsis and proposes a robust diagnostic signatur
Summary
Three papers stood out today: a multicenter cohort introduces critical closing pressure and tissue perfusion pressure as complementary hemodynamic metrics to mean arterial pressure for sepsis risk stratification; a systematic review/meta-analysis summarizes AI models for early sepsis detection, highlighting strong performance but limited real-world validation; and an integrative multi-omics study maps dysregulated programmed cell death pathways in sepsis and proposes a robust diagnostic signature.
Research Themes
- Hemodynamic phenotyping beyond MAP in sepsis
- AI-enabled early detection and implementation science
- Cell death–immunometabolism networks and biomarker discovery in sepsis
Selected Articles
1. Comprehensive analysis of the role of diverse programmed cell death patterns in sepsis.
Integrative bulk and single-cell transcriptomics reveal four upregulated programmed cell death pathways in sepsis and position monocytes as central hubs linking cell death, metabolism, and immune communication. An 18-gene Cell Death-associated Signature (CDS) achieved high diagnostic AUCs across public datasets and an independent RNA-seq cohort, supporting its utility for diagnosis and risk stratification.
Impact: This study uncovers underappreciated cell death modalities in sepsis and delivers a validated transcriptomic signature with high diagnostic performance, offering mechanistic targets and a potential clinical tool.
Clinical Implications: While exploratory, the CDS score could evolve into a diagnostic/triage assay and guide precision immunomodulation targeting monocyte-driven PCD–metabolic axes. Prospective clinical validation is warranted before adoption.
Key Findings
- Four PCD pathways—ferroptosis, disulfidptosis, NETosis, and entotic cell death—were significantly upregulated and correlated with immune infiltration in sepsis.
- An 18-gene CDS risk score achieved AUCs of 0.961 and 0.844 in public datasets and 0.975 in an independent RNA-seq cohort.
- Single-cell analyses highlighted monocytes as dominant effectors with metabolic reprogramming and dysregulated intercellular signaling (MIF–CXCR4, ANXA1–FPR2, HLA–KIR).
Methodological Strengths
- Integration of bulk transcriptomics and scRNA-seq with independent external RNA-seq validation
- Robust analytical pipeline (GSVA, ssGSEA, LASSO, AUCell, CellPhoneDB) with multi-cohort consistency
Limitations
- Observational omics study without interventional validation
- Potential batch effects and limited clinical phenotyping across integrated datasets
Future Directions: Prospective, multicenter validation of the CDS score; development of clinical-grade assays; interventional studies targeting monocyte PCD–metabolic pathways; and evaluation of predictive value for immunotherapies.
BACKGROUND: Sepsis, a life-threatening condition with persistently high mortality, involves dysregulated immune responses and programmed cell death (PCD). However, the specific roles and interactions of diverse PCD pathways in sepsis pathogenesis remain incompletely understood. This study aimed to systematically characterize PCD patterns and their clinical relevance in sepsis. METHODS: We integrated three bulk transcriptomic datasets (81 controls, 165 sepsis patients) and one single-cell RNA sequencing (scRNA-seq) dataset (4 controls, 4 early sepsis patients, 52,315 cells) from public databases. Gene set variation analysis (GSVA) quantified activity of 13 PCD pathways. Immune infiltration was assessed via single-sample gene set enrichment analysis (ssGSEA). A cell death-associated signature (CDS) risk score was developed using least absolute shrinkage and selection operator (LASSO) regression. scRNA-seq analysis identified cell-type-specific PCD activation and intercellular communication using Seurat, AUCell, and CellPhoneDB. Additionally, an independent RNA-seq cohort generated from our own sequencing of sepsis patients and healthy controls was used for external validation. RESULTS: Transcriptomic analysis identified 5,591 differentially expressed genes enriched in immune and cell death pathways. Four PCD pathways-ferroptosis, disulfidptosis, NETosis, and entotic cell death-were significantly upregulated in sepsis and strongly correlated with immune cell infiltration, such as activated dendritic cells and neutrophils. The CDS risk score, based on 18 core PCD genes, showed excellent diagnostic accuracy across both public microarray datasets (AUC = 0.961 and 0.844) and our independent high-throughput RNA-seq dataset (AUC = 0.975). scRNA-seq revealed monocytes as dominant effectors, exhibiting heightened activation of ferroptosis, entotic death, and netotic pathways alongside metabolic reprogramming, including enhanced glutathione metabolism and oxidative phosphorylation (OXPHOS). Furthermore, monocyte-centric intercellular communication was dysregulated in sepsis, featuring upregulated MIF-CXCR4, ANXA1-FPR2, and HLA-KIR signaling axes. CONCLUSIONS: By integrating public microarray and single-cell transcriptomic data with independent high-throughput sequencing validation, this study analysis identifies ferroptosis, disulfidptosis, netotic death, and entotic death as key dysregulated PCD pathways in sepsis, with monocytes serving as central hubs integrating PCD, metabolic reprogramming, and immune communication. The CDS risk score provides a robust diagnostic and stratification tool. Targeting monocyte-driven PCD-metabolism-communication networks offers promising avenues for precision immunotherapy in sepsis.
2. Critical Closing and Tissue Perfusion Pressures in Sepsis-Implications for Risk Stratification: A Retrospective Cohort Study.
In a multicenter cohort of 6,769 septic adults, higher Pcc and lower TPP were associated with worse outcomes independent of MAP, with a U-shaped relationship to mortality and AKI. Classifying patients by TPP and Pcc discriminated ICU mortality (35.1% vs. 20.1%), and results were externally validated in MIMIC-IV.
Impact: Introduces physiologic pressures (Pcc, TPP) that complement MAP for sepsis risk stratification, potentially reshaping hemodynamic targets and monitoring.
Clinical Implications: Bedside estimation of Pcc and TPP could refine blood pressure management and identify patients at risk for mortality and AKI beyond MAP alone; prospective interventional trials should test target-driven strategies incorporating TPP.
Key Findings
- ICU mortality differed markedly across TPP–Pcc strata: 35.1% (Low TPP–Low Pcc) vs. 20.1% (High TPP–High Pcc); risk difference 15.0% (95% CI 10.2–19.8).
- After MAP adjustment, higher Pcc with reduced TPP showed a significant U-shaped association with mortality and AKI (P < 0.001).
- Findings were consistent in external validation using the MIMIC-IV cohort.
Methodological Strengths
- Large multicenter cohort with two independent datasets and external validation (MIMIC-IV)
- Adjusted analyses and physiologically grounded derivation of Pcc/TPP from high-frequency vitals
Limitations
- Retrospective design with potential residual confounding
- Derived Pcc estimates depend on modeling assumptions and data quality
Future Directions: Prospective validation of Pcc/TPP thresholds, randomized testing of TPP-guided hemodynamic targets, and integration into real-time clinical decision support.
BACKGROUND: Optimal target of mean arterial pressure (MAP) remains controversial in sepsis management. Critical closing pressure (Pcc), the arterial pressure at which blood flow ceases, is the key determinant of vascular waterfall phenomenon. Tissue perfusion pressure (TPP), the difference between MAP and Pcc, represents the driving pressure for arterial blood flow. We evaluated the prognostic value of Pcc and TPP for improving risk stratification in sepsis. METHODS: This retrospective cohort study included adult patients with sepsis in 18 hospitals between August 2013 to October 2022 from two independent datasets (the SEPSIS-EDT registry and the critical care database of PUMCH). Pcc was estimated via linear regression of hourly MAP against product of heart rate and pulse pressure, while TPP was calculated as MAP minus Pcc. Patients were categorized into four groups based on the optimal thresholds for mean Pcc and TPP within 24 hours of sepsis diagnosis: Low TPP-Low Pcc, Low TPP-High Pcc, High TPP-Low Pcc, and High TPP-High Pcc. Clinical outcomes included mortality rates and development of acute kidney injury (AKI) within two and seven days of sepsis diagnosis. External validation was performed using MIMIC-IV cohort. RESULTS: A total of 6,769 patients (mean age 61; 61.0% men) were included. ICU mortality was highest in the Low TPP-Low Pcc group and lowest in the High TPP-High Pcc group (35.1% vs. 20.1%; risk difference: 15.0%, 95% confidence interval: 10.2-19.8%). Similar patterns were observed for other outcomes. After adjustment for MAP, increased Pcc with concomitant reduced TPP showed a significant U-shaped association with both mortality and AKI development (P < 0.001). The findings were consistent in the MIMIC-IV cohort. CONCLUSION: While MAP remains central to sepsis management, Pcc and TPP provide complementary prognostic information. Incorporating these parameters into clinical assessment may improve risk stratification and optimize blood pressure management.
3. Artificial Intelligence-Based Predictive Modeling for Early Detection of Sepsis in Hospitalized Patients: A Systematic Review and Meta-Analysis.
Across 52 studies, AI models for early sepsis detection achieve strong performance (AUC 0.79–0.96) using diverse EHR-derived features, including NLP of clinical notes. Yet, most evidence remains retrospective with limited real-time, prospective validation, and key challenges include generalizability, explainability, and workflow integration.
Impact: Provides a state-of-the-art synthesis of AI sepsis prediction, benchmarking performance and clarifying translational gaps to guide future deployment and research.
Clinical Implications: Clinicians and health systems should prioritize AI models with external validation, interpretable outputs, and seamless EHR integration; rigorous prospective trials are needed before widespread clinical adoption.
Key Findings
- Fifty-two studies met inclusion criteria; most were retrospective with limited real-time clinical validation.
- Algorithms included random forests, neural networks, SVMs, and deep learning (LSTM, CNN) using structured and unstructured EHR features.
- Reported AUCs ranged from 0.79 to 0.96; major challenges are generalizability, interpretability, and workflow integration.
Methodological Strengths
- Comprehensive multi-database search with PRISMA-guided extraction
- Cross-comparison of diverse algorithms and feature sets including NLP of clinical notes
Limitations
- Heterogeneity in definitions, cohorts, and endpoints limits meta-analytic pooling and comparability
- Few prospective, real-time validations; potential publication bias
Future Directions: Develop standardized benchmarks, prioritize external and prospective validation, enhance explainability, and evaluate clinical impact via pragmatic trials with EHR-embedded implementation.
OBJECTIVES: This systematic review evaluates artificial intelligence (AI)-based predictive models developed for early sepsis detection in adult hospitalized patients. It explores model types, input features, validation strategies, performance metrics, clinical integration, and implementation challenges. DATA SOURCES: A systematic search was conducted across PubMed, Scopus, Web of Science, Google Scholar, and CENTRAL for studies published between January 2015 and March 2025. STUDY SELECTION: Eligible studies included those developing or validating AI models for adult inpatient sepsis prediction using electronic health record data and reporting at least one performance metric (area under the curve [AUC], sensitivity, specificity, or F1 score). Studies focusing on pediatric populations, lacking quantitative evaluation, or unpublished in peer-reviewed journals were excluded. DATA EXTRACTION: Data extraction followed preferred reporting items for systematic reviews and meta-analyses guidelines. Extracted variables included study design, patient population, model type, input features, validation approach, and performance outcomes. DATA SYNTHESIS: A total of 52 studies met the inclusion criteria. Most used retrospective designs, with limited prospective or real-time clinical validation. Commonly used algorithms included random forests, neural networks, support vector machines, and deep learning architectures (long short-term memory, convolutional neural network). Input data varied from structured sources (vital signs, laboratory values, demographics) to unstructured clinical notes processed via natural language processing. Reported AUC values ranged from 0.79 to 0.96, indicating strong predictive performance across models. CONCLUSIONS: AI models demonstrate significant promise for early sepsis detection, outperforming conventional scoring systems in many cases. However, generalizability, interpretability, and clinical implementation remain major challenges. Future research should emphasize externally validated, explainable, and scalable AI solutions integrated into real-time clinical workflows.